Technical Analysis for RFL - Rafael Holdings, Inc.
Grade | Last Price | % Change | Price Change |
---|---|---|---|
C | 2.00 | 2.56% | 0.05 |
RFL closed up 2.09 percent on Wednesday, November 20, 2024, on 38 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
Earnings due: Dec 12
*** please verify all earnings dates ***ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Up | Up | Up |
Date | Alert Name | Type | % Chg |
---|---|---|---|
MACD Bullish Signal Line Cross | Bullish | 2.56% | |
NR7 | Range Contraction | 2.56% | |
Narrow Range Bar | Range Contraction | 2.56% | |
Up 3 Days in a Row | Strength | 2.56% | |
20 DMA Support | Bullish | 4.71% | |
Crossed Above 50 DMA | Bullish | 4.71% | |
50 DMA Resistance | Bearish | 6.38% | |
Crossed Above 20 DMA | Bullish | 6.38% | |
Gapped Down | Weakness | 6.38% | |
20 DMA Resistance | Bearish | 9.29% |
Alert | Time |
---|---|
60 Minute Opening Range Breakout | about 1 hour ago |
Up 3% | about 1 hour ago |
Up 2% | about 1 hour ago |
Rose Above Previous Day's High | about 3 hours ago |
Rose Above Upper Bollinger Band | about 3 hours ago |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 12/12/2024
Rafael Holdings Inc, through its subsidiaries, is a clinical stage, oncology-focused pharmaceutical company committed to the development and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells.
Sector: Healthcare
Industry: Biotechnology
Keywords: Cancer Cancer Cell Millennium Pharmaceuticals
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Cancer Cancer Cell Millennium Pharmaceuticals
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 2.5 |
52 Week Low | 1.29 |
Average Volume | 47,646 |
200-Day Moving Average | 1.67 |
50-Day Moving Average | 1.90 |
20-Day Moving Average | 1.87 |
10-Day Moving Average | 1.89 |
Average True Range | 0.11 |
RSI (14) | 54.75 |
ADX | 15.74 |
+DI | 21.36 |
-DI | 19.51 |
Chandelier Exit (Long, 3 ATRs) | 1.67 |
Chandelier Exit (Short, 3 ATRs) | 2.06 |
Upper Bollinger Bands | 1.97 |
Lower Bollinger Band | 1.78 |
Percent B (%b) | 0.91 |
BandWidth | 10.02 |
MACD Line | 0.00 |
MACD Signal Line | -0.01 |
MACD Histogram | 0.0049 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 2.00 | ||||
Resistance 3 (R3) | 1.99 | 1.97 | 1.99 | ||
Resistance 2 (R2) | 1.97 | 1.96 | 1.97 | 1.99 | |
Resistance 1 (R1) | 1.96 | 1.95 | 1.97 | 1.97 | 1.98 |
Pivot Point | 1.94 | 1.94 | 1.94 | 1.94 | 1.94 |
Support 1 (S1) | 1.93 | 1.93 | 1.94 | 1.93 | 1.92 |
Support 2 (S2) | 1.91 | 1.92 | 1.91 | 1.91 | |
Support 3 (S3) | 1.90 | 1.91 | 1.91 | ||
Support 4 (S4) | 1.90 |